Clinical Comparative Study to Evaluate the Efficacy and Safety of Recombinant Anti-TNF-alpha Antibodies for Injection
Clinical trial NCT04178850 · UNKNOWN
Trial details
- NCT number
- NCT04178850
- Sponsor
- Genor Biopharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-13
- Primary completion
- 2020-12-01
- Enrollment
- 568
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.